SCHEMBL249660

SCHEMBL249660

[CH2]C[NH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1666440 0.72
SCHEMBL27842 0.61
SCHEMBL190090 0.55
SCHEMBL1167 0.55
SCHEMBL4270839 0.50
SCHEMBL4344311 0.50
SCHEMBL8284 0.50
SCHEMBL40987 0.50
SCHEMBL139791 0.50
SCHEMBL8154549 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2224 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3374421-B1 METHOD OF RECYCLING PHENOL RESIN-CONTAINING MATERIALS, ESPECIALLY PHENOL RESIN-BASED FIBRE COMPOSITE MATERIALS FRAUNHOFER GES FORSCHUNG (DE) 2024-01-24 EP claimed
US-11833120-B2 Binding protein drug conjugates comprising anthracycline derivatives NBE-THERAPEUTICS AG (CH) 2023-12-05 US claimed
US-11759500-B2 PEGylated interferon-beta variant ABION INC. (KR) 2023-09-19 US claimed
CN-116099978-A Three-component amine method cold box binder 济南圣泉集团股份有限公司 2023-05-12 CN claimed
CN-115819100-A Composite material prepared by using thermosetting furfuryl ketone resin reclaimed material and preparation method thereof 陕西美兰德炭素有限责任公司 2023-03-21 CN claimed
CN-114981271-A Novel organic electron transfer mediator and device comprising same 爱-森新株式会社 2022-08-30 CN claimed
US-20210322561-A1 BINDING PROTEIN DRUG CONJUGATES COMPRISING ANTHRACYCLINE DERIVATIVES NBE-THERAPEUTICS AG (CH) 2021-10-21 US claimed
EP-2914630-B1 NOVEL ANTIGEN BINDING PROTEINS AND THEIR USE AS ADDRESSING PRODUCT FOR THE TREATMENT OF CANCER PF MEDICAMENT (FR) 2021-03-03 EP claimed
US-10633507-B2 Method of recycling phenol resin-containing materials, especially phenol resin-based fiber composite materials FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2020-04-28 US claimed
CN-107075047-B Photocurable composition, cured body formed from photocurable composition, and method for producing cured body 高级软质材料株式会社 2020-01-17 CN claimed
EP-0067508-A1 Amidine derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-12-22 EP claimed
EP-0065823-A1 Heterocyclic guanidines as histamine H-2 antagonists IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-12-01 EP claimed
EP-0061318-A2 Guanidinoheterocyclic derivatives as histamine H-2 antagonists IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-29 EP claimed
EP-0061346-A2 Dispersant composition for lubricating oil, additive packages and lubricating oil compositions comprising the dispersant ingredients of said composition, a method of imparting dispersancy to a lubricating oil, and ingredients intended for use in a dispersant mixture EDWIN COOPER INC. (US) 1982-09-29 EP claimed
EP-0060730-A2 Bicyclic derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-22 EP claimed
EP-0060696-A1 Nitrogen heterocycles IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-22 EP claimed
EP-0060697-A1 Heterocyclic derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-22 EP claimed
EP-0060094-A2 Guanidine derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-15 EP claimed
EP-0060093-A2 Amide derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-15 EP claimed
EP-0059597-A2 Guanidino-substituted heterocyclic derivatives having histamine H-2 antagonist activity IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-08 EP claimed